Complementation of two mutant p53: Implications for loss of heterozygosity in cancer

被引:8
作者
Demidenko, ZN
Fojo, T
Blagosklonny, MV
机构
[1] New York Med Coll, Brander Canc Res Inst, Valhalla, NY 10595 USA
[2] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
关键词
cancer; p53; tumor suppressor;
D O I
10.1016/j.febslet.2005.03.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Remarkably, a cancer cell rarely possesses two mutant p53 proteins. Instead, mutation of one allele is usually associated with loss of the second p53 allele. Why do not two mutant p53 co-exist? We hypothesize that two different p53 may complement each other, when expressed at equal levels. By titrating trans-deficient and DNA-binding-deficient p53 in cells with mutant p53 and by co-transfecting distinct mutant p53 in p53-null cells, we demonstrated activation of p53-dependent transcription. We suggest that, due to complementation of two mutant p53, cancer cells need to delete the second p53 allele rather than mutate it. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.Ni. All rights reserved.
引用
收藏
页码:2231 / 2235
页数:5
相关论文
共 43 条
[31]   Characterization of the p53-rescue drug CP-31398 in vitro and in living cells [J].
Rippin, TM ;
Bykov, VJN ;
Freund, SMV ;
Selivanova, G ;
Wiman, KG ;
Fersht, AR .
ONCOGENE, 2002, 21 (14) :2119-2129
[32]   Human lung cancer and p53:: The interplay between mutagenesis and selection [J].
Rodin, SN ;
Rodin, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) :12244-12249
[33]   p53 downstream targets and chemosensitivity [J].
Sax, JK ;
El-Deiry, W .
CELL DEATH AND DIFFERENTIATION, 2003, 10 (04) :413-417
[34]   Reactivation of mutant p53: a new strategy for cancer therapy [J].
Selivanova, G ;
Kawasaki, T ;
Ryabchenko, L ;
Wiman, KG .
SEMINARS IN CANCER BIOLOGY, 1998, 8 (05) :369-378
[35]  
Sigal A, 2000, CANCER RES, V60, P6788
[36]   Inactivation of the apoptosis effector Apaf-1 in malignant melanoma [J].
Soengas, MS ;
Capodieci, P ;
Polsky, D ;
Mora, J ;
Esteller, M ;
Opitz-Araya, X ;
McCombie, R ;
Herman, JG ;
Gerald, WL ;
Lazebnik, YA ;
Cordón-Cardó, C ;
Lowe, SW .
NATURE, 2001, 409 (6817) :207-211
[37]   DOSAGE-DEPENDENT DOMINANCE OVER WILD-TYPE P53 OF A MUTANT P53 ISOLATED FROM NASOPHARYNGEAL CARCINOMA [J].
SUN, Y ;
DONG, ZG ;
NAKAMURA, K ;
COLBURN, NH .
FASEB JOURNAL, 1993, 7 (10) :944-950
[38]  
TAKIMOTO R, 2002, CANC BIOL THER
[39]   Surfing the p53 network [J].
Vogelstein, B ;
Lane, D ;
Levine, AJ .
NATURE, 2000, 408 (6810) :307-310
[40]   Cancer genes and the pathways they control [J].
Vogelstein, B ;
Kinzler, KW .
NATURE MEDICINE, 2004, 10 (08) :789-799